DE60030172D1 - Verfahren zur erzeugung von genetisch veränderten antigenen - Google Patents

Verfahren zur erzeugung von genetisch veränderten antigenen

Info

Publication number
DE60030172D1
DE60030172D1 DE60030172T DE60030172T DE60030172D1 DE 60030172 D1 DE60030172 D1 DE 60030172D1 DE 60030172 T DE60030172 T DE 60030172T DE 60030172 T DE60030172 T DE 60030172T DE 60030172 D1 DE60030172 D1 DE 60030172D1
Authority
DE
Germany
Prior art keywords
useful
genes
methods
cells
genetically modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60030172T
Other languages
English (en)
Other versions
DE60030172T2 (de
Inventor
Nicholas C Nicolaides
Luigi Grasso
Philip M Sass
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphotek Inc
Original Assignee
Morphotek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphotek Inc filed Critical Morphotek Inc
Application granted granted Critical
Publication of DE60030172D1 publication Critical patent/DE60030172D1/de
Publication of DE60030172T2 publication Critical patent/DE60030172T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60030172T 2000-11-14 2000-11-14 Verfahren zur erzeugung von genetisch veränderten antigenen Expired - Lifetime DE60030172T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/031135 WO2002040499A1 (en) 2000-11-14 2000-11-14 A method for generating genetically altered antigens

Publications (2)

Publication Number Publication Date
DE60030172D1 true DE60030172D1 (de) 2006-09-28
DE60030172T2 DE60030172T2 (de) 2007-07-05

Family

ID=21741992

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60030172T Expired - Lifetime DE60030172T2 (de) 2000-11-14 2000-11-14 Verfahren zur erzeugung von genetisch veränderten antigenen

Country Status (8)

Country Link
EP (1) EP1363930B1 (de)
JP (1) JP2005509399A (de)
AT (1) ATE336505T1 (de)
AU (1) AU2001216030A1 (de)
CA (1) CA2429134C (de)
DE (1) DE60030172T2 (de)
DK (1) DK1363930T3 (de)
WO (1) WO2002040499A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917017A (en) * 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
CA2192940C (en) * 1994-06-17 2009-08-11 Robertus Jacobus Maria Moormann Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
AU3241095A (en) * 1994-07-29 1996-03-04 Chiron Corporation Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5843757A (en) * 1995-08-24 1998-12-01 The Johns Hopkins University Human JTV1 gene overlaps PMS2 gene
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms

Also Published As

Publication number Publication date
EP1363930A4 (de) 2004-04-14
DE60030172T2 (de) 2007-07-05
JP2005509399A (ja) 2005-04-14
WO2002040499A1 (en) 2002-05-23
ATE336505T1 (de) 2006-09-15
CA2429134A1 (en) 2002-05-23
AU2001216030A1 (en) 2002-05-27
EP1363930A1 (de) 2003-11-26
CA2429134C (en) 2011-03-15
DK1363930T3 (da) 2006-09-04
EP1363930B1 (de) 2006-08-16

Similar Documents

Publication Publication Date Title
CA2240609A1 (en) A method for generating hypermutable organisms
Stebbins The basis of progressive evolution
HK1083635A1 (en) Animal protein free media for cultivation of cells
AR044246A1 (es) Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas
DK0633929T3 (da) Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener
EP1456374A4 (de) Verfahren zur herstellung und verwendung reprogrammierter menschlicher somatischer zellkerne sowie autologer und isogener menschlicher stammzellen
IL170221A (en) Progenitor cells from wharton's jelly of human umbilical cord and methods of obtaining and utilizing same
CY1112409T1 (el) Μοναδα και διεργασια για διεξαγωγη ζυμωσης υψηλης κυτταρικης πυκνοτητας
NO20054124L (no) Dyre-fri celle kultur metode
EP1391511A4 (de) Künstliches menschliches chromosom mit dem gen für die lambda-leichte kette menschlicher antikörper
DK1159415T3 (da) Genetisk modifikation af somatiske celler og anvendelse deraf
ATE501635T1 (de) Chemische hemmstoffe des mismatch-repair
DE60039371D1 (de) Methode zur herstellung hypermutabler pflanzen
WO2001088192A3 (en) A method for generating hypermutable organisms
CN105505879A (zh) 一种培养转基因动物胚胎细胞或转基因动物的方法及培养基
DE60329366D1 (de) Induktierbare transposition beim transgenen organismus mit transposon-vektor
DE69935907D1 (de) Hocheffizienzverfahren und zusammensetzungen zum integrieren von exogener dna in genomische sperma-dna
DE60030172D1 (de) Verfahren zur erzeugung von genetisch veränderten antigenen
CN109722436A (zh) 基于CRISPR-Cas9的基因组无痕编辑的载体与应用
ATE489474T1 (de) Verfahren zur erzeugung verbesserter antikörper produzierender zellinien mit verbesserten wachstumseigenschaften
ES2074560T3 (es) Procedimiento para la produccion de un animal transgenico no humano mediante la introduccion de adn exogeno en celulas animales somaticas y germinales.
DE60143810D1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
CN106973868B (zh) 极早期电晕解除家蚕滞育卵滞育性的方法及其产品
ATE447968T1 (de) Impfung mit immunisolierten und einen immunomodulator produzierenden zellen
ATE446005T1 (de) Durch verstärktes wachstum charakterisierte pflanzen sowie für deren erzeugung geeignete verfahren und nukleinsäurekonstrukte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DRAUDT, A., DIPL.-ING., PAT.-ANW., 42289 WUPPERTAL